Angioplasty Balloons Market Report
First published: 23 October 2024 | Last updated: 22 April 2026 | Report Code: angioplasty-balloons
Angioplasty Balloons Market — USD $4.5 Billion in 2023, Growing to USD 8.84B by 2033 at 6.8% CAGR
This report provides a comprehensive analysis of the Angioplasty Balloons market from 2023 to 2033, covering market size, trends, and forecasts. It offers insights into industry dynamics, segmentation, regional performance, and competitive landscape, crucial for stakeholders in making informed decisions.
Key Takeaways
- Global revenues rise from $4.50 Billion in 2023 to $8.84 Billion by 2033, reflecting sustained demand for minimally invasive vascular interventions.
- Projected expansion follows a 6.8% CAGR over the 2023 to 2033 forecast period, driven by clinical adoption and device innovation.
- North America is both the largest and fastest-growing market, with regional revenues increasing from $1.46 Billion to $2.88 Billion.
- Drug-eluting and specialty balloon designs are gaining share across hospitals, cardiac catheterization labs and ambulatory surgery centers.
- Market leadership is concentrated among Boston Scientific Corporation, Medtronic Plc., Abbott Laboratories, B. Braun Melsungen AG and Cook Medical.
Angioplasty Balloons Market Report — Executive Summary
This report outlines a detailed market assessment of angioplasty balloons, capturing market size, segmentation, regional performance and vendor positioning. The market stood at $4.50 Billion in 2023 and is forecast to reach $8.84 Billion by 2033 at a 6.8% CAGR over the 2023 to 2033 period. Growth is supported by rising cardiovascular disease prevalence, an aging population and broader acceptance of less invasive interventional procedures. Technological advances — such as improved balloon materials and drug-eluting coatings — are improving clinical outcomes and expanding indications. The analysis covers product types, materials, end users and distribution channels, and includes profile-level insights on leading suppliers. Regional breakdowns highlight North America as both the largest and fastest-growing market, while Europe and Asia Pacific present notable expansion opportunities. The competitive review examines strategic moves by established manufacturers and the shifting mix of hospital and outpatient settings.
Key Growth Drivers
- Rising incidence of cardiovascular conditions increases procedural demand for balloon angioplasty devices.
- Aging demographics expand the patient pool requiring interventional cardiology solutions.
- Advances in drug-eluting and specialty balloon technologies improve clinical efficacy and reduce restenosis rates.
- Shifts toward minimally invasive procedures boost use in hospitals, cardiac catheterization labs and ambulatory surgery centers.
- Government investments in healthcare infrastructure and streamlined regulatory pathways accelerate product adoption.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $4.50 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $8.84 Billion |
| Top Companies | Boston Scientific Corporation, Medtronic Plc., Abbott Laboratories, B. Braun Melsungen AG, Cook Medical |
| Published Date | 23 October 2024 |
| Last Modified Date | 22 April 2026 |
Angioplasty Balloons Market Overview
Customize Angioplasty Balloons Market Report market research report
- ✔ Get in-depth analysis of Angioplasty Balloons market size, growth, and forecasts.
- ✔ Understand Angioplasty Balloons's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Angioplasty Balloons
What is the Market Size & CAGR of Angioplasty Balloons Market Report market in 2023?
Angioplasty Balloons Industry Analysis
Angioplasty Balloons Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Angioplasty Balloons Market Report Market Analysis Report by Region
Europe Angioplasty Balloons Market Report:
Europe’s market expands from $1.15 Billion in 2023 to $2.25 Billion in 2033. Adoption is supported by established interventional cardiology programs, ongoing device innovation and healthcare investments that favor minimally invasive treatment options.Asia Pacific Angioplasty Balloons Market Report:
Asia Pacific grows from $0.92 Billion in 2023 to $1.81 Billion in 2033, reflecting increasing access to interventional care, rising cardiovascular disease prevalence and expanding hospital and outpatient capacity across the region.North America Angioplasty Balloons Market Report:
North America is both the largest and fastest-growing region, with revenues increasing from $1.46 Billion in 2023 to $2.88 Billion in 2033. Growth is underpinned by advanced healthcare infrastructure, high procedure volumes, rapid uptake of drug-eluting and specialty balloons, and a strong presence of leading device manufacturers.South America Angioplasty Balloons Market Report:
Middle East & Africa Angioplasty Balloons Market Report:
Middle East and Africa increase from $0.54 Billion in 2023 to $1.05 Billion in 2033, supported by investments in cardiovascular services, expanding specialist training and gradual diffusion of newer balloon materials and drug-eluting options.Tell us your focus area and get a customized research report.
Research Methodology
Angioplasty Balloons Market Analysis By Product
The Angioplasty Balloons market is segmented by product into bare metal balloons, drug-eluting balloons, and specialty balloons. In 2023, bare metal balloons hold a significant market size of $2.89 billion, expected to increase to $5.68 billion by 2033 with a steady market share of 64.24%. Drug-eluting balloons are projected to grow from $1.23 billion to $2.41 billion, holding 27.3% market share, while specialty balloons, despite being smaller in size, will reach $0.75 billion by 2033 with a market share of 8.46%. This segmentation reflects the clinical adaptations to improve patient outcomes in various demographic profiles.
Angioplasty Balloons Market Analysis By Application
The market is further segmented by application into coronary angioplasty, peripheral angioplasty, balloon angioplasty in children, and other applications. Coronary angioplasty leads the market at $2.48 billion in 2023, expected to rise to $4.88 billion, capturing 55.14% market share. Peripheral angioplasty follows with a market size of $1.04 billion in 2023, projected to grow to $2.05 billion, holding 23.18% market share. Each application highlights the adaptability of angioplasty balloons to various patient needs and conditions.
Angioplasty Balloons Market Analysis By End User
The end-user segmentation consists of hospitals, ambulatory surgery centers, and cardiac catheterization labs. Hospitals dominate the market with a size of $2.89 billion in 2023, aiming for $5.68 billion by 2033, representing a substantial share of 64.24%. Ambulatory surgery centers hold $1.23 billion currently, forecasted to grow to $2.41 billion, while cardiac catheterization labs account for $0.38 billion, aiming to reach $0.75 billion. These segments illustrate the varied environmental settings for angioplasty procedures and their respective impact on market dynamics.
Angioplasty Balloons Market Analysis By Material
The segmentation by material includes polymer balloons, metal balloons, and composite balloons. Polymer balloons lead with $2.89 billion in 2023, projected to grow to $5.68 billion, maintaining a dominant share of 64.24%. Metal balloons, capturing a 27.3% share, are expected to rise from $1.23 billion to $2.41 billion, while composite balloons expand from $0.38 billion to $0.75 billion across the forecast period. This segmentation reflects the continuing importance of material innovation in enhancing efficacy and safety in angioplasty procedures.
Angioplasty Balloons Market Analysis By Distribution Channel
The distribution channel market is divided into direct sales, distributors, and e-commerce. Direct sales lead with $2.89 billion in 2023, likely to project growth to $5.68 billion with a consistent share of 64.24%. Distributors, holding a market size of $1.23 billion, are projected to rise to $2.41 billion, while e-commerce remains a smaller but growing segment from $0.38 billion to $0.75 billion. This delineation highlights the evolving methods of market engagement and the transition towards digital platforms.
Angioplasty Balloons Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Angioplasty Balloons Industry
Boston Scientific Corporation:
A leading global medical device manufacturer known for its innovative products, including angioplasty balloons, Boston Scientific focuses heavily on the development of drug-eluting technologies that enhance patient outcomes.Medtronic Plc.:
Medtronic is a prominent player in the angioplasty balloon market, offering a wide range of balloon products designed to treat various cardiovascular conditions, driving innovation through research and development.Abbott Laboratories:
Abbott is recognized for its advanced medical devices, specifically its drug-eluting balloons that have revolutionized angioplasty procedures. It emphasizes technological advancements and improved recovery outcomes.B. Braun Melsungen AG:
B. Braun specializes in medical and pharmaceutical products, including angioplasty balloons, focusing on quality and safety in the treatment of various cardiovascular conditions.Cook Medical:
Cook Medical has a diverse portfolio within the vascular product space, including angioplasty balloons, and is noted for its commitment to innovation in vascular therapy.We're grateful to work with incredible clients.
FAQs
What is the market size of angioplasty balloons in 2023?
The global angioplasty balloons market was valued at $4.50 Billion in 2023. The report details regional and segment breakdowns and sets the baseline for forecasts covering 2023 to 2033.
How big will the market be in 2033?
By 2033 the market is projected to reach $8.84 Billion according to the provided forecast, reflecting cumulative growth across products, materials and regional markets through 2033.
What is CAGR for the forecast period?
The market is forecast to grow at a 6.8% compound annual growth rate over the 2023 to 2033 period, driven by technological advances and increased procedure volumes.
Why is North America significant in this market?
North America is both the largest and fastest-growing region, with revenues rising from $1.46 Billion in 2023 to $2.88 Billion in 2033, supported by advanced care settings and rapid technology adoption.
Which regions show notable growth potential?
Europe and Asia Pacific demonstrate meaningful expansion: Europe grows from $1.15 Billion to $2.25 Billion, and Asia Pacific from $0.92 Billion to $1.81 Billion between 2023 and 2033.
Who are the leading companies in the market?
Key vendors listed include Boston Scientific Corporation, Medtronic Plc., Abbott Laboratories, B. Braun Melsungen AG and Cook Medical, representing major technology and distribution footprints.
What end users are covered in the segmentation?
Primary end-user categories include hospitals, ambulatory surgery centers and cardiac catheterization labs, reflecting varied care settings and procedure migration trends.
Which product types dominate the market?
Product segmentation highlights bare metal balloons, drug-eluting balloons and specialty balloons, each serving different clinical needs and influencing adoption across applications.
What drives adoption of drug Eluting balloons?
Drug-eluting balloons gain traction due to improved anti-restenosis properties and favorable clinical outcomes, encouraging uptake in coronary and peripheral angioplasty procedures.
How is the market research conducted?
The study combines primary interviews with industry experts and secondary sources such as company reports, with data triangulation and expert-led trend validation to ensure robust findings.